Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.

Gullón A, Formiga F, Díez-Manglano J, Mostaza JM, Cepeda JM, Pose A, Castiella J, Suárez-Fernández C; NONAVASC study group Vascular Risk Group of the Spanish Society of Internal Medicine.

Intern Emerg Med. 2019 Jan;14(1):59-69. doi: 10.1007/s11739-018-1938-3. Epub 2018 Sep 6.

PMID:
30191535
2.

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators.

N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27.

3.

Acute kidney injury is linked to higher mortality in elderly hospitalized patients with non-valvular atrial fibrillation.

Novo-Veleiro I, Pose-Reino A, Gullón A, Díez-Manglano J, Cepeda JM, Formiga F, Camafort M, Mostaza JM, Suárez C.

Aging Clin Exp Res. 2018 Jul 17. doi: 10.1007/s40520-018-1001-2. [Epub ahead of print]

PMID:
30019264
4.

Rivaroxaban: searching the integral vascular protection.

Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazón P, Camafort M, Cepeda JM, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C.

Expert Rev Clin Pharmacol. 2018 Jul;11(7):719-728. doi: 10.1080/17512433.2018.1495559. Epub 2018 Jul 18. Review.

PMID:
29965791
5.

Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation.

Díez-Manglano J, Mostaza JM, Pose A, Formiga F, Cepeda JM, Gullón A, Camafort M, Castiella J, Rovira E, Jarauta E, Suárez C.

Geriatr Gerontol Int. 2018 Aug;18(8):1219-1224. doi: 10.1111/ggi.13451. Epub 2018 Jun 13.

PMID:
29897154
6.

miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.

Escate R, Mata P, Cepeda JM, Padró T, Badimon L.

FASEB J. 2018 Feb;32(2):601-612. doi: 10.1096/fj.201700476RR.

PMID:
29457550
7.

miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.

Escate R, Mata P, Cepeda JM, Padró T, Badimon L.

FASEB J. 2018 Jan 4:fj201700476R. doi: 10.1096/fj.201700476R. [Epub ahead of print]

PMID:
29089446
8.

Baseline functional status as the strongest predictor of in-hospital mortality in elderly patients with non-valvular atrial fibrillation: Results of the NONAVASC registry.

Gullón A, Formiga F, Camafort M, Mostaza JM, Díez-Manglano J, Cepeda JM, Novo-Veleiro I, Pose A, Suárez Fernández C; NONAVASC study group. Vascular Risk Group of the Spanish Society of Internal Medicine.

Eur J Intern Med. 2018 Jan;47:69-74. doi: 10.1016/j.ejim.2017.09.020. Epub 2017 Sep 24.

PMID:
28954714
9.

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Fernández-Pérez C, Muñiz O, Díaz-Díaz JL, Saltijeral A, Fuentes-Jiménez F, de Andrés R, Zambón D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea Á, Sanchez Muñoz-Torrero JF, Padró T, Argueso R, Miramontes-González JP, Badimón L, Santos RD, Watts GF, Mata P.

Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.

PMID:
28275165
10.

Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.

Gullón A, Suárez C, Díez-Manglano J, Formiga F, Cepeda JM, Pose A, Camafort M, Castiella J, Rovira E, Mostaza JM; en representación de los investigadores del estudio NONAVASC.

Med Clin (Barc). 2017 Mar 3;148(5):204-210. doi: 10.1016/j.medcli.2016.10.042. Epub 2016 Dec 16. English, Spanish.

PMID:
27993408
11.

A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.

Pinyol C, Cepeda JM, Roldan I, Roldan V, Jimenez S, Gonzalez P, Soto J.

Cardiol Ther. 2016 Dec;5(2):171-186. Epub 2016 Jul 25.

12.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators.

N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

13.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Perez de Isla L, Alonso R, Watts GF, Mata N, Saltijeral Cerezo A, Muñiz O, Fuentes F, Diaz-Diaz JL, de Andrés R, Zambón D, Rubio-Marin P, Barba-Romero MA, Saenz P, Sanchez Muñoz-Torrero JF, Martinez-Faedo C, Miramontes-Gonzalez JP, Badimón L, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85. doi: 10.1016/j.jacc.2016.01.008.

14.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators.

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107. Epub 2015 Aug 5.

PMID:
26296047
15.

[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].

Conthe P, Cepeda JM.

Med Clin (Barc). 2014 Mar;142 Suppl 1:32-5. doi: 10.1016/S0025-7753(14)70080-6. Review. Spanish.

PMID:
24930081
16.

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.

17.

Features and costs of patients admitted for cardiac arrhythmias in Spain.

Montes-Santiago J, Rodil V, Formiga F, Cepeda JM, Urrutia A; Working Group on Heart Failure and Atrial Fibrillation of the Spanish Society of Internal Medicine (SEMI).

Rev Clin Esp (Barc). 2013 Jun-Jul;213(5):235-9. doi: 10.1016/j.rce.2013.02.003. Epub 2013 Apr 3. English, Spanish.

PMID:
23561445
18.

[Paradox of obesity in heart failure: results from the Spanish RICA Registry].

Trullàs JC, Formiga F, Montero M, Conde A, Casado J, Carrasco FJ, Díez J, Ceresuela LM; Grupo RICA.

Med Clin (Barc). 2011 Dec 10;137(15):671-7. doi: 10.1016/j.medcli.2011.03.036. Epub 2011 Jun 29. Spanish.

PMID:
21719051
19.

[Safety and tolerance of beta-blocker treatment in elderly patients with heart failure. BETANIC study].

Yebra-Yebra M, Recio J, Arévalo-Lorido JC, Cornide-Santos L, Cerqueiro-González JM, Manzano L; BETANIC.

Med Clin (Barc). 2010 Feb 13;134(4):141-5. doi: 10.1016/j.medcli.2009.07.016. Epub 2009 Oct 27. Spanish.

PMID:
19863974
20.

[Neisseria meningitidis pneumoniae in a 47 year old woman with systemic lupus].

Royo-Villanova C, Cepeda JM, Navarro V.

Enferm Infecc Microbiol Clin. 2001 Apr;19(4):188-9. Spanish. No abstract available.

PMID:
11333613

Supplemental Content

Loading ...
Support Center